Valuation: Samsung Biologics Co.,Ltd.

Capitalization 67,076B 44.94B 38.57B 35.21B 33.54B 61.64B 4,304B 62.25B 421B 163B 2,047B 169B 165B 7,133B P/E ratio 2026 *
35.2x
P/E ratio 2027 * 29.9x
Enterprise value 65.22B 43.7M 37.5M 34.24M 32.61M 59.94M 4.19B 60.53M 409M 159M 1.99B 164M 161M 6.94B EV / Sales 2026 *
12x
EV / Sales 2027 * 9.71x
Free-Float
25.52%
Yield 2026 *
-
Yield 2027 * 0.03%
1 day+2.77%
1 week+44.90%
Current month+44.90%
1 month+44.90%
3 months+44.90%
6 months+44.90%
Current year+44.90%
1 week 1,000,000
Extreme 999999.9999
1,449,000
1 month 1,000,000
Extreme 999999.9999
1,449,000
Current year 1,000,000
Extreme 999999.9999
1,449,000
1 year 1,000,000
Extreme 999999.9999
1,449,000
3 years 1,000,000
Extreme 999999.9999
1,449,000
5 years 1,000,000
Extreme 999999.9999
1,449,000
10 years 192,960.76
Extreme 192960.7607
1,449,000
Manager TitleAgeSince
Chief Executive Officer 64 09/12/2020
Director of Finance/CFO 58 14/03/2025
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Chairman 64 09/12/2020
Director/Board Member 72 29/03/2022
Director/Board Member 67 20/03/2020
Change 5d. change 1-year change 3-years change Capi.($)
+2.77%+44.90%+44.90%+44.90% 43.78B
-0.97%-1.13%+24.16%-4.23% 73.24B
+0.50%+1.82%+53.40%+181.91% 53.3B
-1.55%-21.94%-59.61%-68.25% 34.82B
-6.43%+0.36%+55.38%-38.19% 30.2B
-0.77%+2.54%+96.27%-61.31% 20.01B
-1.20%-2.22%+60.55%+49.56% 19.74B
-0.40%-4.30%+73.40%+118.11% 19.29B
-0.14%-0.54%+45.52%+86.01% 16.28B
+1.53%+2.31%+109.44%+414.29% 13.44B
Average -0.59%-1.53%+50.34%+72.28% 32.41B
Weighted average by Cap. -0.57%-1.67%+39.89%+51.90%

Financials

2026 *2027 *
Net sales 5,419B 3.63B 3.12B 2.84B 2.71B 4.98B 348B 5.03B 33.98B 13.2B 165B 13.63B 13.34B 576B 6,555B 4.39B 3.77B 3.44B 3.28B 6.02B 421B 6.08B 41.1B 15.96B 200B 16.49B 16.13B 697B
Net income 1,906B 1.28B 1.1B 1B 953M 1.75B 122B 1.77B 11.95B 4.64B 58.15B 4.79B 4.69B 203B 2,244B 1.5B 1.29B 1.18B 1.12B 2.06B 144B 2.08B 14.07B 5.46B 68.48B 5.64B 5.52B 239B
Net Debt -1,851B -1.24B -1.06B -972M -925M -1.7B -119B -1.72B -11.6B -4.51B -56.47B -4.65B -4.55B -197B -3,436B -2.3B -1.98B -1.8B -1.72B -3.16B -220B -3.19B -21.54B -8.37B -105B -8.64B -8.46B -365B
Logo Samsung Biologics Co.,Ltd.
Samsung Biologics Co Ltd is a Korea-based company primarily engaged in the production of antibody drugs. The Company operates through two segments. The Contract Development and Manufacturing Organization (CDMO) segment primarily provides biopharmaceutical contract manufacturing and cell line development services. The Biopharmaceutical Development and Commercialization segment primarily engages in the development and commercialization of biosimilars.
Employees
5,195
Date Price Change Volume
14/05/26 1,449,000.00 +2.77% 75,777
13/05/26 1,410,000.00 -2.29% 76,826
12/05/26 1,443,000.00 -1.03% 84,654
11/05/26 1,458,000.00 -0.95% 67,575
08/05/26 1,472,000.00 +0.27% 62,693
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
1,449,000.00KRW
Average target price
2,163,528.63KRW
Spread / Average Target
+49.31%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A207940 Stock